Mehran Sugar Mills Limited (MRNS)
Feb 11, 2025 - MRNS was delisted (reason: acquired by Immedica)
0.5500
+0.0010 (0.09%)
Inactive · Last trade price
on Feb 11, 2025
Company Description
Mehran Sugar Mills Limited manufactures and sells sugar and its by-products in Pakistan.
The company offers white refined cane and brown sugar under the Sugarie and Chashnik brand names. It also provides sugar byproducts, such as molasses and bagasse.
Mehran Sugar Mills Limited was incorporated in 1965 and is headquartered in Karachi, Pakistan.
Mehran Sugar Mills Limited
| Country | Pakistan |
| Founded | 1965 |
| IPO Date | Jul 31, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 278 |
| CEO | Ahmed Hasham |
Contact Details
Address: Executive Tower Karachi, Pennsylvania 75600 Pakistan | |
| Phone | 92 21 3529 7814 |
| Website | mehransugar.com |
Stock Details
| Ticker Symbol | MRNS |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | PKR |
| CIK Code | 0001267813 |
| CUSIP Number | 56854Q200 |
| ISIN Number | US56854Q1013 |
| SIC Code | 2060 |
Key Executives
| Name | Position |
|---|---|
| Dr. Scott N. Braunstein M.D. | Chief Executive Officer, President and Chairman |
| Steven E. Pfanstiel C.M.A., M.B.A. | Chief Operating Officer, Chief Financial Officer and Treasurer |
| Dr. Joseph Hulihan M.D. | Chief Medical Officer |
| Dr. Alex Aimetti Ph.D. | Chief Scientific Officer |
| Sonya Weigle | Senior Vice President of Investor Relations, Human Resources and Corporate Affairs |
| Martha E. Manning Esq., J. D. | Senior Vice President, General Counsel and Secretary |
| Molly Cameron | Director of Corporate Communications and Investor Relations |
| Dr. Kimberly A. McCormick Pharm.D. | Chief Regulatory and Quality Assurance Officer |
| Christina Shafer | Chief Commercial Officer |
| David Czekai | Chief Chemistry, Manufacturing and Controls Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 12, 2025 | SCHEDULE 13G/A | Filing |
| Feb 11, 2025 | SCHEDULE 13G | Filing |
| Feb 11, 2025 | SCHEDULE 13G/A | Filing |
| Feb 11, 2025 | SCHEDULE 13G/A | Filing |
| Feb 11, 2025 | 25-NSE | Filing |
| Feb 11, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 11, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 11, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 11, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Feb 11, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |